Ambev S.A. (ABEV)
$2.49 0.01 (0.40%)
19:55 EDT ABEV Stock Quote Delayed 30 Minutes
Previous Close $2.49
Market Cap 39.14B
PE Ratio -
Volume (Avg. Vol.) 25.25M
Day's Range 2.40 - 2.51
52-Week Range 1.90 - 4.94
Dividend & Yield 0.15 (5.82%)
ABEV Stock Predictions, Articles, and Ambev S.A. News
- From InvestorPlace
- From the Web
Assets in the sin-stock category struggled during the pandemic, but Ambev stock's punishment was excessive and a rebound could be imminent.
South America is taking a wretched blow from the coronavirus, thus crushing beer sales. But Ambev stock is well-positioned to bounce back.
Each of these penny stocks holds significant long-term promise, along with some undeniable risk too. Here's what you need should know about each company.
Weak economic growth, EBITDA margin contraction are key challenges. Non-alcoholic beverages growth is a positive.
A surprisingly poor beer market and broader market fears have plagued Ambev stock to near irrelevance. However, an emerging-market rethink could help ABEV over the very long-term picture.
Although a risky play due to competitive threats and political controversies, Ambev stock offers a compelling contrarian opportunity for risk-takers.
Ambev’s 15-year total annual return is quite good at 11.2%. That trails both its brewing peers and the Brazilian market at 13.5%. However, the entire U.S. market over this period could only muster a total return of 9.3%.
Ambev stock is cheaper after a pullback, and historically has paid a solid dividend. But there are risks to both the industry and its key markets.
Over the past year, AmBev stock became one of the ugliest names on Wall Street. However, the last Q2 earnings report confirms that positive fundamentals in the Latin American market support the case for a recovery.
With a list of almost 30 large-cap stocks under $10, here are three to consider buying for your portfolio now.
For some time, Ambev stock has been a loser -- but things may be improving, as the Brazilian economy comtinues to get better.
Changes in consumer habits have pressured beverage-makers, but the industry might be making a comeback, and these are some of the premiere beverage stocks to buy.
After taking a pause in its uptrend, marijuana stocks could get a lift again as Molson Coors shops for companies in this sector. Though the sector has yet to prove it is profitable, a buyout will lift nearly all marijuana stocks.
ABEV stock has been weak in 2018 despite a broad recovery in the Brazil economy, but dip buyers should wait for more weakness before pulling the trigger.
The Buy recommendation for Ambev SA resulted from an analytical process that is proprietary which generated outcomes that were above average in 5 area: an economic sector rated above average in attractiveness, an industry group rated above average in attractiveness, a ranking in the company's sector that is in the top third, ranking in its industry group that is in the top half, and a mathematical computation of risk/reward that is attractive; and produced below average conclusions in 1 areas: an analytical score that is below average.
Ambev SA's Buy recommendation is the outcome of a process of analysis that is proprietary and produced results that were above average in 5 areas: an economic sector ranked above average in attractiveness, an industry group ranked above average in attractiveness, a ranking in the company's sector that is in the top half, ranking in the company's industry group that is in the top half, and a numerical calculation of risk/reward that is attractive; and produced below average outcomes in 1 area: analytical scores that are below average.
The current recommendation of Buy for Ambev SA (NYSE:ABEV) is derived using Louis Navellier's investing approach and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 2 months.
Navellier RatingsPowered by Portfolio Grader